Adpkd (autosomal dominant polycystic kidney disease)
Clinical trials for Adpkd (autosomal dominant polycystic kidney disease) explained in plain language.
Never miss a new study
Get alerted when new Adpkd (autosomal dominant polycystic kidney disease) trials appear
Sign up with your email to follow new studies for Adpkd (autosomal dominant polycystic kidney disease), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a pill tame polycystic kidney disease? early safety trial begins
Knowledge-focused Recruiting nowThis early-stage trial is the first to test GV-100, an oral drug being developed for autosomal dominant polycystic kidney disease (ADPKD), in healthy volunteers. The study aims to assess the drug's safety, tolerability, and how the body processes it, including the effects of food…
Matched conditions: ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE)
Phase 1 • Sponsor: Gilva Therapeutics Inc. • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Kidney disease drug under the microscope: how does tolvaptan really work?
Knowledge-focused Recruiting nowThis study is tracking up to 2,000 people with autosomal dominant polycystic kidney disease (ADPKD) who are taking or considering tolvaptan. Researchers will collect real-world data on dosing, side effects, and kidney function over time. The goal is to understand how the drug is …
Matched conditions: ADPKD (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE)
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC